ARCHIVES

O’Leary Leads RPCI’s OR;

This article is from The Cancer Letter archive.

Vol. 28 No. 06 | February 8, 2002

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

In Brief: Gallo Lists Followup Projects For Human Cancer Virus; Zubrod Responds To Cancer Program Critics

April 11, 1975

DFCI Puts The Cancer Letter On Its Intranet For Employees.

February 11, 2000

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975

Also in this 8-page issue: Despite press reports, no settlement date yet for Bristol-Myers pact with federal prosecutors.

June 10, 2005